METOCLOPRAMIDE-BAXTER metoclopramide (as hydrochloride) solution for injection 10 mg/2 mL ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

metoclopramide-baxter metoclopramide (as hydrochloride) solution for injection 10 mg/2 ml ampoule

baxter healthcare pty ltd - metoclopramide hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: citric acid monohydrate; sodium citrate dihydrate; sodium hydroxide; hydrochloric acid; water for injections; nitrogen; sodium chloride - adults (20 years or older): - relief of nausea and vomiting associated with migraine, cancer therapy (chemotherapy or radiation), malignant disease, labour, infectious disease and uraemia. - control of post-operative vomiting - assist in small bowel intubation.,metoclopramide is of little benefit for the prevention or treatment of motion sickness.,young adults and children (over 1 year of age): metoclopramide should be restricted to the following conditions and only used as second line therapy, when used to treat children and young adults under 20 years of age because of the risk of adverse effects - severe intractable vomiting of known cause - vomiting associated with radiation therapy or intolerance to cytotoxic drugs. - assist in small bowel intubation

MORPHINE SULFATE 30 mg/1 mL MEDSURGE morphine sulfate pentahydrate 30 mg/1 mL solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

morphine sulfate 30 mg/1 ml medsurge morphine sulfate pentahydrate 30 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 30 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 10 mg/1 mL MEDSURGE morphine sulfate pentahydrate 10 mg/1 mL solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

morphine sulfate 10 mg/1 ml medsurge morphine sulfate pentahydrate 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 2 mg/1 mL MEDSURGE morphine sulfate pentahydrate 2 mg/1 mL solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

morphine sulfate 2 mg/1 ml medsurge morphine sulfate pentahydrate 2 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 2 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 15 mg/1 mL MEDSURGE morphine sulfate pentahydrate 15 mg/1 mL solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

morphine sulfate 15 mg/1 ml medsurge morphine sulfate pentahydrate 15 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 15 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 5 mg/1 mL MEDSURGE morphine sulfate pentahydrate 5 mg/1 mL solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

morphine sulfate 5 mg/1 ml medsurge morphine sulfate pentahydrate 5 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 5 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MIDAZOLAM VIATRIS 50 mg/ 10 mL midazolam solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

midazolam viatris 50 mg/ 10 ml midazolam solution for injection ampoule

alphapharm pty ltd - midazolam, quantity: 50 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - intravenously (iv) as an agent for: . - conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid . - induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. .,intermittent iv administration or continuous infusion for: . - sedation in intensive care units, intermittent administration or continuous infusion.,intramuscularly (im) for: . - preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events

MIDAZOLAM VIATRIS 5mg/1mL midazolam solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

midazolam viatris 5mg/1ml midazolam solution for injection ampoule

alphapharm pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium chloride - intravenously (iv) as an agent for: . - conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid . - induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. .,intermittent iv administration or continuous infusion for: . - sedation in intensive care units, intermittent administration or continuous infusion.,intramuscularly (im) for: . - preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events

MIDAZOLAM VIATRIS 5 mg/5 mL midazolam solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

midazolam viatris 5 mg/5 ml midazolam solution for injection ampoule

alphapharm pty ltd - midazolam, quantity: 5 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - intravenously (iv) as an agent for: . - conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid . - induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. .,intermittent iv administration or continuous infusion for: . - sedation in intensive care units, intermittent administration or continuous infusion.,intramuscularly (im) for: . - preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events

MIDAZOLAM VIATRIS 15 mg/ 3 mL midazolam solution for injection ampoule Australië - Engels - Department of Health (Therapeutic Goods Administration)

midazolam viatris 15 mg/ 3 ml midazolam solution for injection ampoule

alphapharm pty ltd - midazolam, quantity: 15 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; sodium chloride - intravenously (iv) as an agent for: . - conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid . - induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. .,intermittent iv administration or continuous infusion for: . - sedation in intensive care units, intermittent administration or continuous infusion.,intramuscularly (im) for: . - preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events